The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner
- PMID: 11403963
- DOI: 10.1016/s0304-3940(01)01872-9
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner
Abstract
The type 3 serotonin (5-HT(3)) receptor is a ligand-gated ion channel. In concentration-clamp experiments, we investigated the effects of the uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists memantine, amantadine and MRZ 2/579 on 5-HT receptors stabley expressed in HEK-293 cells and on native 5-HT(3) receptors in the N1E-115 cell line. All agents antagonized serotonin (10 microM)-induced inward currents with similar potency to that reported for NMDA receptors. This effect was characterized by inducing a pronounced receptor desensitization, and was probably non-competitive and voltage-independent. In contrast, (S)-ketamine was much weaker as an antagonist of 5-HT(3) receptors than NMDA receptors. Similar effects on 5-HT(3) receptors have been reported previously for a variety of anti-depressants and it is possible that the clinical anti-depressant effects reported for both memantine and amantadine are mediated, at least in part, by antagonistic effects at 5-HT(3) receptors.
Similar articles
-
Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.Neuropharmacology. 1999 Jan;38(1):85-108. doi: 10.1016/s0028-3908(98)00161-0. Neuropharmacology. 1999. PMID: 10193901
-
A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization.J Neural Transm (Vienna). 2007;114(12):1529-37. doi: 10.1007/s00702-007-0792-7. Epub 2007 Aug 31. J Neural Transm (Vienna). 2007. PMID: 17728997
-
Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.Br J Pharmacol. 1996 Sep;119(2):195-204. doi: 10.1111/j.1476-5381.1996.tb15971.x. Br J Pharmacol. 1996. PMID: 8886398 Free PMC article.
-
Memantine and the amino-alkyl-cyclohexane MRZ 2/579 are moderate affinity uncompetitive NMDA receptor antagonists--in vitro characterisation.Amino Acids. 2000;19(1):157-66. doi: 10.1007/s007260070044. Amino Acids. 2000. PMID: 11026484 Review.
-
Amino-alkyl-cyclohexanes as a novel class of uncompetitive NMDA receptor antagonists.Curr Pharm Des. 2002;8(10):835-43. doi: 10.2174/1381612024607117. Curr Pharm Des. 2002. PMID: 11945134 Review.
Cited by
-
Memantine: a review of its use in Alzheimer's disease.Drugs. 2006;66(11):1515-34. doi: 10.2165/00003495-200666110-00015. Drugs. 2006. PMID: 16906789 Review.
-
Glutamate and Its Receptors as Therapeutic Targets for Migraine.Neurotherapeutics. 2018 Apr;15(2):361-370. doi: 10.1007/s13311-018-0616-5. Neurotherapeutics. 2018. PMID: 29508147 Free PMC article. Review.
-
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552. Pharmacol Rev. 2021. PMID: 33370241 Free PMC article. Review.
-
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy.Med Res Rev. 2021 Sep;41(5):2689-2745. doi: 10.1002/med.21719. Epub 2020 Aug 11. Med Res Rev. 2021. PMID: 32783388 Free PMC article. Review.
-
Effects of haloperidol inhalation on MK-801- and memantine-induced locomotion in mice.Libyan J Med. 2020 Dec;15(1):1808361. doi: 10.1080/19932820.2020.1808361. Libyan J Med. 2020. PMID: 32808583 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous